Clinical Trial Update: Effect of Sitagliptin on Polycystic Ovarian Syndrome Patients [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on sitagliptin for polycystic ovary syndrome across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Beni-Suef University | Conditions: Polycystic Ovary Syndrome | Phase 2, Phase 3 | Status: UNKNOWN